Clinical Trials of interest to cytokine & interferon researchers. Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT ClinicalTrials.gov ID NCT06130579 Sponsor: Peking University People’s Hospital Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party) Last Update Posted 2024-03-21 MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Pegylated Interferon Lambda for Treatment of COVID-19 Infection ClinicalTrials.gov ID NCT04534673 Sponsor Soroka University Medical Center Information provided by Ohad Etzion, Soroka University Medical Center (Responsible Party) Last Update Posted 2023-05-06 Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC) ClinicalTrials.gov ID NCT05867004 Sponsor Institut Claudius Regaud Information provided by Institut Claudius Regaud (Responsible Party) Last Update Posted 2023 Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? (BIOSTOP) ClinicalTrials.gov ID NCT03011268 Sponsor Helse Møre og Romsdal HF Information provided by Helse Møre og Romsdal HF (Responsible Party) Last Update Posted 2023-03-17 Evaluation of [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers huCART19-IL18 in NHL/CLL Patients ClinicalTrials.gov ID NCT04684563 Sponsor University of Pennsylvania Information provided by University of Pennsylvania (Responsible Party) Last Update Posted 2024-05-13 Low Dose IL-2 for the Treatment of Crohn’s Disease ClinicalTrials.gov ID NCT04263831 Sponsor Boston Children’s Hospital Information provided [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers Non-Eosinophilic Biological Effects of IL-5 ClinicalTrials.gov ID NCT06026202 Sponsor Imperial College London Information provided by Imperial College London (Responsible Party) Last Update Posted 2023-10-30 A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov ID NCT06287528 Sponsor Memorial Sloan [READ MORE]
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP (FoxP3ITP) ClinicalTrials.gov ID NCT05410249 Sponsor Sohag University Information provided by Noha Saber Shafik, Sohag University (Responsible Party) Last Update Posted 2023-04-12 Targeting IL-17A for Treatment-Resistant Depression ClinicalTrials.gov ID NCT04979910 Sponsor Icahn School of Medicine at Mount Sinai [READ MORE]
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients (IGNORANT) ClinicalTrials.gov ID NCT05843786 Sponsor Hospices Civils de Lyon Information provided by Hospices Civils de Lyon (Responsible Party) Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis (ATIOM) ClinicalTrials.gov ID NCT05535764 Sponsor University [READ MORE]
Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory CancersClinicalTrials.gov ID NCT03388632Sponsor National Cancer Institute (NCI)Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party) Interleukin-34 Level in Periodontal DiseaseClinicalTrials.gov ID NCT05962567Sponsor Ain Shams UniversityInformation provided by Nada Zidan, Ain Shams University (Responsible Party) TNFalpha and Interleukin 2 [READ MORE]
Clinical Trials of interest to cytokine & interferon researchers [READ MORE]
International Cytokine & Interferon Society, Copyright 2024 Website Design by Rhema Association Management | Privacy Policy
